News
Novo Nordisk unveils $499 cash-pay Ozempic offering amid continued compounder competition
Several months after unveiling its direct-to-consumer NovoCare Pharmacy service with the launch of a $499 cash-pay option for a monthly supply of Wegovy, Novo Nordisk is expanding the discount to include its other GLP-1 heavyweight.
Novo Nordisk offers lower Ozempic price for customers whose insurance does not cover costs
People who are prescribed Ozempic to treat type 2 diabetes, but whose insurance does not cover it, or who don’t have insurance, will be able to buy the medication at a lower cost. Novo Nordisk announced on Monday that it will offer Ozempic for $499 a month through the GoodRx platform.
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...
The Ozempic price cut could appease US President Donald Trump, who has pushed for drug companies to lower their prices.
13hon MSN
Why Novo Nordisk Stock Popped Monday
Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Some women are complaining of 'Ozempic vulva' and GLP-1 medications can causes changes to women's private parts.
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
Novo Nordisk A/S (NYSE:NVO) is one of the best falling stocks to buy now. On August 7, HSBC maintained a “Hold” rating on ...
SINGAPORE] Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback